Publications:

PARP inhibitor resistance: the underlying mechanisms and clinical implications.

Molecular Cancer

Li, He H; Liu, Zhao-Yi ZY; Wu, Nayiyuan N; Chen, Yong-Chang YC; Cheng, Quan Q; Wang, Jing J

Publication Date: 2020-06-20

Variant appearance in text: BRCA2: Q2009del

PubMed Link: 32563252

Variant Present in the following documents:

• Main text
• 12943_2020_Article_1227.pdf

View BVdb publication page

Polyclonal BRCA2 mutations following carboplatin treatment confer resistance to the PARP inhibitor rucaparib in a patient with mCRPC: a case report.

Bmc Cancer

Simmons, Andrew D AD; Nguyen, Minh M; Pintus, Elias E

Publication Date: 2020-03-14

Variant appearance in text: BRCA2: Q2009del

PubMed Link: 32171277

Variant Present in the following documents:

• Main text
• 12885_2020_Article_6657.pdf

View BVdb publication page